Effects of Gwaruhaengryeon-hwan on COPD and Particulate Matter Induced Lung Injury on a Mouse Model
![]() |
Lee, Chul-wha
(Dept. of Internal Medicine, College of Korean Medicine, Dae-Jeon University)
Yang, Won-kyung (Dept. of Internal Medicine, College of Korean Medicine, Dae-Jeon University) Lyu, Yee-ran (Dept. of Internal Medicine, College of Korean Medicine, Dae-Jeon University) Kim, Seung-hyeong (Institute of Traditional Medicine and Bioscience, Dae-Jeon University) Park, Yang-chun (Dept. of Internal Medicine, College of Korean Medicine, Dae-Jeon University) |
1 | Borchers MT, Carty MP, Leikauf GD. Regulation of human airway mucins by acrolein and inflammatory mediators. Am J Physiol 1999;276(4 Pt 1):549-55. |
2 | Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2017 Report. Available from: http://www.goldcopd.org. Accessed Nov 11, 2016. |
3 | Yoo CG. Pathogenesis and pathophysiology of COPD. Korean J Intern Med 2009;77(4):383-400. |
4 | Pelkonen M. Smoking: relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality. CurrOpinPulm Med 2008;14(2):105-9. |
5 | Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117:398S-401S. DOI |
6 | Sint T, Donohue JF, Ghio AJ. Ambient air pollution particles and the acute exacerbation of chronic obstructive pulmonary disease. InhalToxicol 2008;20(1):25-9. |
7 | Ling SH, van Eeden SF. Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009;4:233-43. |
8 | World Health Organization. Air pollution including WHO's 1999 guidelines for air pollution control. Geneva: World Health Organization; 2000. |
9 | Pope CA, Ezzati M, Dockery DW. Fine-particulate air pollution and life expectancy in the United States. N Engl J Med 2009;360:376-86. DOI |
10 | Lee BJ, Jung HJ, Choi JY, Kang W, Jung SK. Preliminary study to develop a Korean oriental medicine assessment tool for syndrome differentiation of chronic obstructive pulmonary disease. J Korean Oriental Med 2012;33(3):82-94. |
11 | Lee ES, Han JM, Kim MH, Namgung U, Yeo Y, Park YC. Effects of inhalable microparticles of Socheongryong-tang on chronic obstructive pulmonary disease in a mouse model. J Korean Med 2013;34(3):54-68. DOI |
12 | Lee JG, Yang SY, Kim MH, Namgung U, Park YC. Protective effects of Socheongryong-tang on elastase-induced lung injury. J Korean Oriental Med 2011;32(4):83-99. |
13 | Kim HW, Yang SY, Kim MH, Namgung U, Park YC. Protective effects of Maekmundong-tang on elastase-induced lung injury. J Korean Oriental Med 2011;32(2):63-78. |
14 | Kim Y, Yang SY, Kim MH, Namgung U, Park YC. Effects of Saengmaekcheongpye-eum on LPS-induced COPD model. Korean J Oriental Int Med 2011;32(2):217-31. |
15 | Lee H, Kim Y, Kim HJ, Park S, Jang YP, Jung S, et al. Herbal Formula, PM014, Attenuates Lung Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease. Evid Based Complement Alternat Med 2012;2012:769830. |
16 | Han JM, Yang WK, Kim SH, Park YC. Effects of Sagan-tang and individual herbs on COPD mice model. J Korean Med Soc Herb Formula Study 2015;23(2):171-87. |
17 | Hur J. Dong-Eui-Bo-Gam. Seoul: Namsandang; 1986, p. 473. |
18 | Jung YM, Lee HY. Chronic Obstructive Pulmonary Disease in Korea: Prevalence, Risk Factors, and Quality of Life. J Korean Acad Nurs 2011;41(2):149-56. DOI |
19 | Food and Drug Administration. Revision of the Guidelines for Measures for Hazard component of inhibitor of smoking desire. Available at: http://www.mfds.go.kr. Accessed Nov 1, 2014. |
20 | Kim SH, Park YC, Lee JE, Yang WK, Choi JJ, Oh JG. Method for preparing mouse model induced ambient particulate matter. Korea Patent 10-2016-0156279, Nov. 23, 2016. |
21 | Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008;118(11):3546-56. DOI |
22 | Lambrecht BN, Prins JB, Hoogsteden HC. Lung dendritic cells and host immunity to infection. Eur Respir J 2001;18(4):692-704. |
23 | Wang G, Xu Z, Wang R, Al-Hijji M, Salit J, Strulovici-Barel Y, et al. Genes associated with MUC5AC expression in small airway epithelium of human smokers and nonsmokers. BMC Med Genomics 2012;5:21. DOI |
24 | Chen L, Yang W, Jennison BL, Omaye ST. Air particulate pollution and hospital admissions for chronic obstructive pul-monary disease in Reno, Nevada. Inhal Toxicol 2000;12(4):281-98. DOI |
25 | Sunyer J, Basagana X. Particles, and not gases, are associated with the risk of death in patients with chronic obstructive pulmonary disease. Int J Epidemiol 2001;30(5):1138-40. DOI |
26 | McCreanor J, Cullinan P, Nieuwenhuijsen MJ, Stewart-Evans J, Malliarou E, Jarup L, et al. Respiratory effects of exposure to diesel traffic in persons with asthma. N Engl J Med 2007;357(23):2348-58. DOI |
27 | Gang BS, Kim IR, Kim HC, Guk YB, Park YG, Seo BI, et al. Bonchohak. Seoul: Younglimsa; 2006, p. 180-1, 461-2, 478-9. |
28 | Aaron SD, Angel JB, Lunau M, Wright K, Fex C, Le Saux N, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163(2):349-55. DOI |
29 | Schaberg T, Haller H, Rau M, Kaiser D, Fassbender M, Lode H. Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokers. Eur Respir J 1992;5(4):387-93. |
30 | Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153(2):530-4. DOI |
31 |
Deveci Y, Deveci F, Ilhan N, Karaca I, Turgut T, Muz MH. Serum ghrelin, IL-6 and |
32 | Levanen B, Glader P, Dahlen B, Billing B, Qvarfordt I, Palmberg L, et al. Impact of tobacco smoking on cytokine signaling via interleukin-17A in the peripheral airways. Int J Chron Obstruct Pulmon Dis 2016;11:2109-16. DOI |
33 | Lukacs NW, Hogaboam CM, Kunkel SL. Chemokines and their receptors in chronic pulmonary disease. Curr Drug Targets Inflamm Allergy 2005;4(3):313-7. DOI |
34 |
Traves SL, Culpitt SV, Russell RE, Barnes PJ, Donnelly LE. Increased levels of the chemokines |
35 | Guzman K, Gray TE, Yoon JH, Nettesheim P. Quantitation of mucin RNA by PCR reveals induction of both MUC2 and MUC5AC mRNA levels by retinoids. Am J Physiol 1996;271(6 Pt 1):1023-8. |
![]() |